Elafibranor Inhibits Chronic Kidney Disease Progression in NASH Mice

Identification of new pharmacological approaches to inhibit the excessive fat intake-induced steatohepatitis and chronic kidney disease (CKD) is important. High-fat diet (HFD)-induced steatohepatitis and CKD share common pathogenesis involving peroxisome proliferator-activated receptor (PPAR)-α and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biomed Res Int
Auteurs principaux: Tsai, Hung-Cheng, Chang, Fu-Pang, Li, Tzu-Hao, Liu, Chih-Wei, Huang, Chia-Chang, Huang, Shiang-Fen, Yang, Ying-Ying, Lee, Kuei-Chuan, Hsieh, Yun-Cheng, Wang, Ying-Wen, Lee, Tzung-Yan, Huang, Yi-Hsiang, Hou, Ming-Chih, Lin, Han-Chieh
Format: Artigo
Langue:Inglês
Publié: Hindawi 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607733/
https://ncbi.nlm.nih.gov/pubmed/31321239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/6740616
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires